alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 30, Issue 1, 1999, Pages 110-114

  Tangkijvanich, Pisit ^a   Tosukhowong, Piyarat ^a   Bunyongyod, Pichet ^a   Lertmaharit, Somrat ^a   Hanvivatvong, Orrawadee ^a   Kullavanijaya, Pinit ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ALPHA LEVO FUCOSIDASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD; CANCER STAGING; CASE CONTROL STUDY; CHRONIC HEPATITIS; CLASSIFICATION; ENZYMOLOGY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THAILAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ALPHA-L-FUCOSIDASE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THAILAND; TUMOR MARKERS, BIOLOGICAL;

EID: 0033084758     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bukofzer S, Stass PM, Kew MC, de Beer M, Groeneveld HT. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks. Br J Cancer 1989; 59: 417-20.
2. Chen DS, Sung JL, Sheu JC, et al. Serum α-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984; 86: 1404-9.
3. Colombo M. Should patients with chronic viral hepatitis be screened for hepatocellular carcinoma? Viral Hepatitis Rev 1995; 1: 67-75.
4. Deugnier Y, David V, Brissot P, et al. Serum α-L-fucosidase: A new marker for the diagnosis of primary hepatic carcinoma. Hepatology 1984; 4: 889-92.
5. Di Bisceglie AM, Hoffnagle JH. Elevation in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 1989; 64: 2117-20.
6. Holmes EH, Hakomori SI. Isolated and charaterisation of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2-acetylaminofluorine. J Biol Chem 1982; 257: 7698.
7. Giardina MG, Matarazzo M, Varriale A, et al. Serum alpha-L-fucosidase: A useful marker in the diagnosis of hepatocellular carcinoma. Cancer 1992; 70: 1044-8.
8. Leray G, Deugnier Y, Jouanolle AM, et al. Biochemical aspects of α-L-fucosidase in hepatocellular carcinoma. Hepatology 1989; 9: 249-52
9. Lok ASF, Lai CL. α-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989; 9: 110-5.
10. Marotta F, Chui DH, Safran P, Zhang SC. Serum α-L-fucosidase. A more sensitive marker for hepatocellular carcinoma? Dig Dis Sci 1991; 7: 993-7.
11. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-38.
12. Pateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20: 65-71.
13. Takahashi H, Saibara T, Iwamura S, et al. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma. Hepatology 1994; 19: 1414-7.
14. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Clinical evaluation of serum α-fetoprotein and circulating immune complexes as tumor markers of hepatocellular carcinoma. Br J Cancer 1995; 72: 442-6.
15. Vischer P, Reutter W. Specific patterns of fucoprotein biosynthesis in the plasma membranes of Morris hepatoma 7777. Eur J Biochem 1978; 84: 363.
16. Zielke K, Okada S, O'Brien J. Fucosidase: diagnosis by serum assay of alpha-L-fucosidase. J Lab Clin Med 1972: 79; 164-9.